Literature DB >> 9389513

Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells.

C B Cleutjens1, K Steketee, C C van Eekelen, J A van der Korput, A O Brinkmann, J Trapman.   

Abstract

Androgen receptor-positive LNCaP cells were stably transfected with a rat glucocorticoid receptor (GR) expression plasmid. Ligand-binding studies in the generated cell lines revealed high-affinity binding of the cognate ligands to their receptors. Transfection experiments with the newly derived cell lines showed that, like androgen receptor, GR can induce activity of a prostate-specific antigen promoter fragment linked to the luciferase gene. Similarly, dexamethasone can stimulate expression of endogenous prostate-specific antigen messenger RNA. Cell proliferation could be induced by R1881. In contrast, dexamethasone treatment of the GR-positive sublines had no stimulatory effect on cell growth. Using the differential display technique, a so far unknown complementary DNA fragment, designated 21.1, specifically induced by androgens and not by glucocorticoids, has been identified. In conclusion, the newly generated cell lines, together with the parental LNCaP cell line, form an attractive system with which to study the mechanism of specificity of steroid hormone regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389513     DOI: 10.1210/endo.138.12.5564

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  FOXA1: master of steroid receptor function in cancer.

Authors:  Michael A Augello; Theresa E Hickey; Karen E Knudsen
Journal:  EMBO J       Date:  2011-09-20       Impact factor: 11.598

2.  Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.

Authors:  Ryan J Austin; Heidi M Smidansky; Carly A Holstein; Deborah K Chang; Angela Epp; Neil C Josephson; Daniel B Martin
Journal:  Proteomics       Date:  2011-12-12       Impact factor: 3.984

3.  Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription.

Authors:  James Thompson; Tatyana Lepikhova; Neus Teixido-Travesa; Maria A Whitehead; Jorma J Palvimo; Olli A Jänne
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

Review 4.  The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.

Authors:  Jieping Hu; Qingke Chen
Journal:  Int Urol Nephrol       Date:  2016-12-16       Impact factor: 2.370

5.  Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.

Authors:  Jacob Kach; Tiha M Long; Phillip Selman; Eva Y Tonsing-Carter; Maria A Bacalao; Ricardo R Lastra; Larischa de Wet; Shane Comiskey; Marc Gillard; Calvin VanOpstall; Diana C West; Wen-Ching Chan; Donald Vander Griend; Suzanne D Conzen; Russell Z Szmulewitz
Journal:  Mol Cancer Ther       Date:  2017-04-20       Impact factor: 6.261

6.  Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

Authors:  Russell Z Szmulewitz; Elizabeth Chung; Hikmat Al-Ahmadie; Silver Daniel; Masha Kocherginsky; Aria Razmaria; Gregory P Zagaja; Charles B Brendler; Walter M Stadler; Suzanne D Conzen
Journal:  Prostate       Date:  2011-05-11       Impact factor: 4.104

7.  Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.

Authors:  Jan-Hendrik Bebermeier; James D Brooks; Samuel E DePrimo; Ralf Werner; Uta Deppe; Janos Demeter; Olaf Hiort; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2006-08-24       Impact factor: 4.599

8.  Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.

Authors:  Masis Isikbay; Kristen Otto; Steven Kregel; Jacob Kach; Yi Cai; Donald J Vander Griend; Suzanne D Conzen; Russell Z Szmulewitz
Journal:  Horm Cancer       Date:  2014-03-11       Impact factor: 3.869

9.  Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.

Authors:  Biswajyoti Sahu; Marko Laakso; Kristian Ovaska; Tuomas Mirtti; Johan Lundin; Antti Rannikko; Anna Sankila; Juha-Pekka Turunen; Mikael Lundin; Juho Konsti; Tiina Vesterinen; Stig Nordling; Olli Kallioniemi; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

10.  Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.

Authors:  Kersten Berndt; Marcus Kim; Andreas Meinhardt; Jörg Klug
Journal:  Mol Cell Biochem       Date:  2007-09-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.